← Back to Intel
Insider ActivityNBP
Hagler Mark Arnold, See Remarks at NovaBridge Biosciences, bought $577K of NBP
Updated Jun 21, 2026
Hagler Mark Arnold
See Remarks
NovaBridge Biosciences ·
$NBP
Transaction Details
| Insider | Hagler Mark Arnold |
|---|---|
| Title | See Remarks |
| Company | NovaBridge Biosciences |
| Ticker | NBP |
| Transaction Type | Purchase |
| Transaction Date | 2026-04-24 |
| Shares Traded | 230,000 |
| Price Per Share | $2.51 |
| Total Value | $577K |
| Filed Date | 2026-04-28 |
| Accession Number | 0001193125-26-186924 |
Ownership Context
| Shares Owned After Transaction | 230,000 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001193125-26-186924
Other Insider Trades — NBP
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Xu Cong Claire | SVP, Clinical Development | sold | $14K | 2026-06-01 |
| Xu Cong Claire | SVP, Clinical Development | traded | — | 2026-05-30 |
| Xu Cong Claire | SVP, Clinical Development | traded | — | 2026-05-30 |
| Cao Sean Wuxiong | See Remarks | sold | $43K | 2026-05-14 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for NBP — NovaBridge Biosciences →
Track NBP insider activity in real time on The Wire →
Get alerts when Hagler Mark Arnold files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 21, 2026 at 07:19 UTC